Antiviral treatment | Daily dose of aciclovir (mg) | Daily urine volume (ml) | Estimated GFR <60 ml/min/1.73m2 | Serum creatine (mg/dl) |
---|---|---|---|---|
Day 0 | 1000 [750 -1500]; n = 58 | 2300 [1550-3175]; n = 59 | 41.1 [21.1-50.1]; n = 19 | 1.01 [0.66-1.23]; n = 55 |
Day 1 | 2250 [1500-2250]; n = 58 | 2700 [1800-3600]; n = 59 | 40.5 [22.4-47.3]; n = 22 | 0.93 [0.67-1.39]; n = 57 |
Day 2 | 2100 [1400-2250]; n = 57 | 2404 [1435-3438]; n = 58 | 44.7 [27.8-51.7]; n = 25 | 1.04 [0.68-1.35]; n = 57 |
Day 3 | 1850 [1150-2250]; n = 52 | 2620 [1390-3813]; n = 52 | 41.6 [31.7-47.4]; n = 22 | 0.96 [0.65-1.50]; n = 51 |
Day 4 | 2000 [1000-2250]; n = 45 | 2900 [2000-3350]; n = 45 | 40.3 [20.3-45.2]; n = 17 | 0.97 [0.69-1.42]; n = 44 |
Day 5 | 2000 [1260-2250]; n = 36 | 3220 [2075-4293]; n = 36 | 41.3 [38.4-50.1]; n = 17 | 1.04 [0.67-1.46]; n = 37 |
Day 6 | 2250 [1500-2250]; n = 34 | 2725 [1928-3868]; n = 34 | 42.0 [39.5-48.0]; n = 14 | 0.97 [0.66-1.44]; n = 33 |
Day 7 | 2125 [1500-2250]; n = 30 | 2800 [2075-4075]; n = 30 | 42.3 [37.8-48.8]; n = 12 | 0.84 [0.62-1.35]; n = 31 |